Do analysts prefer ACB or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media refer more to ACB or CGC?

In the previous week, Canopy Growth had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.06 beat Canopy Growth's score of 0.39 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 3 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend CRON or ACB?

Cronos Group currently has a consensus target price of $2.30, suggesting a potential downside of 18.15%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer CRON or ACB?

In the previous week, Cronos Group had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Cronos Group and 2 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 1.26 beat Aurora Cannabis' score of 1.06 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend OGI or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer ACB or SNDL?

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, analysts plainly believe SNDL is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, ACB or SNDL?

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aurora Cannabis $247.82M 0.70 -$88.13M -$1.56 N/A SNDL $677.32M 0.52 -$11.29M -$0.03 N/A

Is ACB or SNDL more profitable?

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Aurora Cannabis -33.57% 0.10% 0.07% SNDL -1.19% -1.02% -0.85%

Does the media favor ACB or SNDL?

In the previous week, Aurora Cannabis and Aurora Cannabis both had 2 articles in the media. Aurora Cannabis' average media sentiment score of 1.06 beat SNDL's score of 0.94 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer TLRY or ACB?

Tilray Brands presently has a consensus price target of $11.50, suggesting a potential upside of 147.84%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities research analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer TLRY or ACB?

In the previous week, Tilray Brands had 18 more articles in the media than Aurora Cannabis. MarketBeat recorded 20 mentions for Tilray Brands and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.06 beat Tilray Brands' score of 0.67 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 8 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aurora Cannabis (ACB) Competitors

$2.83 +0.07 (+2.54%)

Closing price 04:00 PM Eastern

Extended Trading

$2.84 +0.01 (+0.32%)

As of 07:56 PM Eastern

Compare

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Aurora Cannabis compare to Canopy Growth?

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

Aurora Cannabis has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.06 beat Canopy Growth's score of 0.39 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aurora Cannabis has higher earnings, but lower revenue than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A
Canopy Growth	$251.01M	1.67	-$190.29M	-$0.59	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Aurora Cannabis has a net margin of -33.57% compared to Canopy Growth's net margin of -75.27%. Aurora Cannabis' return on equity of 0.10% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Canopy Growth	-75.27%	-26.95%	-17.20%

Summary

Canopy Growth beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	7.15	-$9.45M	$0.01	281.00
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Aurora Cannabis	-33.57%	0.10%	0.07%

Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

Cronos Group currently has a consensus target price of $2.30, suggesting a potential downside of 18.15%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cronos Group had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Cronos Group and 2 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 1.26 beat Aurora Cannabis' score of 1.06 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cronos Group beats Aurora Cannabis on 12 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Aurora Cannabis	-33.57%	0.10%	0.07%

In the previous week, Aurora Cannabis had 1 more articles in the media than Organigram Global. MarketBeat recorded 2 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Aurora Cannabis' score of 1.06 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
Aurora Cannabis	Positive

Organigram Global has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

Organigram Global has higher earnings, but lower revenue than Aurora Cannabis. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.78	-$17.70M	-$0.13	N/A
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Organigram Global beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to SNDL?

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

In the previous week, Aurora Cannabis and Aurora Cannabis both had 2 articles in the media. Aurora Cannabis' average media sentiment score of 1.06 beat SNDL's score of 0.94 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, SNDL has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A
SNDL	$677.32M	0.52	-$11.29M	-$0.03	N/A

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
SNDL	-1.19%	-1.02%	-0.85%

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, analysts plainly believe SNDL is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Aurora Cannabis and SNDL tied by winning 6 of the 12 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Tilray Brands had 18 more articles in the media than Aurora Cannabis. MarketBeat recorded 20 mentions for Tilray Brands and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.06 beat Tilray Brands' score of 0.67 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	8 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.66	-$2.19B	-$13.65	N/A
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A

Tilray Brands presently has a consensus price target of $11.50, suggesting a potential upside of 147.84%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities research analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Tilray Brands has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

Aurora Cannabis has a net margin of -33.57% compared to Tilray Brands' net margin of -156.51%. Aurora Cannabis' return on equity of 0.10% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Aurora Cannabis	-33.57%	0.10%	0.07%

Summary

Tilray Brands and Aurora Cannabis tied by winning 8 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$169.31M	$8.39B	$6.79B	$12.17B
Dividend Yield	N/A	2.54%	2.68%	5.91%
P/E Ratio	-1.81	15.91	25.79	24.19
Price / Sales	0.70	5.78	519.93	82.79
Price / Cash	3.93	17.16	46.33	53.91
Price / Book	0.45	3.36	10.77	6.37
Net Income	-$88.13M	$226.25M	$3.57B	$337.69M
7 Day Performance	-3.41%	0.44%	3.15%	-0.30%
1 Month Performance	-18.21%	-1.88%	2.33%	0.36%
1 Year Performance	-33.57%	0.69%	33.42%	26.94%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	0.9404 of 5 stars	$2.83 +2.5%	N/A	-29.6%	$169.31M	$247.82M	N/A	1,028	Positive News
CGC Canopy Growth	1.1607 of 5 stars	$0.96 -1.0%	N/A	-25.8%	$390.87M	$251.01M	N/A	3,150
CRON Cronos Group	1.2834 of 5 stars	$2.65 -2.2%	$2.30 -13.2%	+44.4%	$1.01B	$146.59M	265.27	450	Positive News
OGI Organigram Global	0.849 of 5 stars	$0.96 -0.5%	N/A	-27.3%	$135.80M	$185.07M	N/A	1,139	Positive News
SNDL SNDL	3.4579 of 5 stars	$1.40 -1.4%	$5.00 +257.1%	+9.8%	$365.50M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACB) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Summary

How does Aurora Cannabis compare to Cronos Group?

Summary

How does Aurora Cannabis compare to Organigram Global?

Summary

How does Aurora Cannabis compare to SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Which has more volatility and risk, ACB or CGC?

Do institutionals & insiders hold more shares of ACB or CGC?

Does the media refer more to ACB or CGC?

Which has better valuation and earnings, ACB or CGC?

Do analysts prefer ACB or CGC?

Is ACB or CGC more profitable?

Summary

How does Aurora Cannabis compare to Cronos Group?

Which has stronger earnings & valuation, CRON or ACB?

Do institutionals and insiders hold more shares of CRON or ACB?

Is CRON or ACB more profitable?

Which has more volatility and risk, CRON or ACB?

Do analysts recommend CRON or ACB?

Does the media prefer CRON or ACB?

Summary

How does Aurora Cannabis compare to Organigram Global?

Do analysts recommend OGI or ACB?

Is OGI or ACB more profitable?

Does the media prefer OGI or ACB?

Which has more volatility & risk, OGI or ACB?

Which has better valuation & earnings, OGI or ACB?

Do institutionals & insiders hold more shares of OGI or ACB?

Summary

How does Aurora Cannabis compare to SNDL?

Does the media favor ACB or SNDL?

Which has more risk and volatility, ACB or SNDL?

Do institutionals and insiders believe in ACB or SNDL?

Which has higher earnings and valuation, ACB or SNDL?

Is ACB or SNDL more profitable?

Do analysts prefer ACB or SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Do insiders & institutionals hold more shares of TLRY or ACB?

Does the media prefer TLRY or ACB?

Which has preferable valuation and earnings, TLRY or ACB?

Do analysts prefer TLRY or ACB?

Which has more volatility & risk, TLRY or ACB?

Is TLRY or ACB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools